Ambalal Sarabhai’s JV receives CDSCO license to manufacture SARAGENE Dengue Test Kit

17 Sep 2021 Evaluate

CoSara Diagnostics, a Joint Venture (JV) of a subsidiary of Ambalal Sarabhai Enterprises and Co-Diagnostics, Inc, has obtained regulatory approval from Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell SARAGENE Dengue Test Kit. The tests are now available for sale.

SARAGENE Dengue Test Kit is an in vitro diagnostic test, based on Real-Time Polymerase Chain Reaction Technology. Test utilizes Co-Diagnostics' patented CoPrimers technology (Satterfield, 2014) (Poritz & Ririe, 2014). It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.

Ambalal Sarabhai Ent Share Price

26.07 -0.02 (-0.08%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×